EB-2 NIWBiotech and pharmaIndividualDecided June 2021Dismissed
Outcome: Dismissed
JUN142021_02B5203
Merit and national importanceMetWell positionedNot metBalance favors a waiverNot reached / not discussed
Our summary
Pharmaceutical scientist seeks national interest waiver of job offer requirement under EB-2. Met first prong showing substantial merit and national importance of proposed drug formulation research, but failed second prong lacking sufficient evidence of positioning to advance the work.
Official PDF
Official PDF ↗Published by USCIS. The summary is ours, in our own words; the decision text is on uscis.gov.
What the AAO accepted
- Merit and national importance · Proposed pharmaceutical research has broader field implications via journals and conferences
What was missing
- Well positioned · Education alone insufficient; citation counts not contemporaneous; no major research funding primary responsibility shown
Criteria
| Criterion | Reading | Why |
|---|---|---|
 Merit and national importance | Met | Proposed pharmaceutical research has broader field implications via journals and conferences |
 Well positioned | Not met | Education alone insufficient; citation counts not contemporaneous; no major research funding primary responsibility shown |
 Balance favors a waiver | Not reached / not discussed | Not reached because second prong failed |
A published decision describes one case. It is not legal advice and not a prediction for yours.